Second trimester maternal plasma and amniotic fluid adipokines in women who will develop gestational diabetes mellitus

References

• Nolan CJ. Controversies in gestational diabetes. Best Pract Res Clin Obstet Gynaecol 2011;25:37–49
   PubMed Web of Science ®Google Scholar
• Hollander MH, Paarlberg KM, Huisjes AJ. Gestational diabetes: a review of the current literature and guidelines. Obstet Gynecol Surv 2007;62:125–36
   PubMed Web of Science ®Google Scholar
• Londero AP, Bertozzi S, Visentin S, et al. High placental index and poor pregnancy outcomes: a retrospective study of 18 386 pregnancies. Gynecol Endocrinol 2013;29:666–9
   PubMed Web of Science ®Google Scholar
• Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991–2002
   PubMed Web of Science ®Google Scholar
• Kiess W, Petzold S, Topfer M, et al. Adipocytes and adipose tissue. Best Practice Res Clin Endocrinol Metab 2008;22:135–53
   PubMed Web of Science ®Google Scholar
• Gulcelik NE, Usman A, Gurlek A. Role of adipocytokines in predicting the development of diabetes and its late complications. Endocrine 2009;36:397–403
   PubMed Web of Science ®Google Scholar
• D'Ippolito S, Tersigni C, Scambia G, Di Simone N. Adipokines, an adipose tissue and placental product with biological functions during pregnancy. Biofactors 2012;38:14–23
   PubMed Web of Science ®Google Scholar
• Visentin S, Lapolla A, Londero AP, et al. Adiponectin levels are reduced while markers of systemic inflammation and aortic remodelling are increased in intrauterine growth restricted mother-child couple. Biomed Res Int 2014;2014:401595
   PubMed Web of Science ®Google Scholar
• Miehle K, Stepan H, Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf) 2012;76:2–11
   PubMed Web of Science ®Google Scholar
• Modena AB, Fieni S. Amniotic fluid dynamics. Acta Biomed 2004;75:11–13
   PubMedGoogle Scholar
• Fruscalzo A, Bertozzi S, Londero AP, et al. Menstrual abnormalities and predisposition to pregnancy-related hypertensive disorders: a retrospective study. Gynecol Endocrinol 2010;26:445–50
   PubMed Web of Science ®Google Scholar
• Driul L, Londero AP, Salvador S, et al. Retrospective analysis of one year of cesarean sections: indications and risk factors associated with intrapartum cesarean section. Minerva Ginecol 2010;62:403–14
   PubMedGoogle Scholar
• Driul L, Londero AP, Bertozzi S, et al. Pregnancy outcome and neonatal health by mothers aged 40 years and over. J Med Med Sci 2010;1:148–55
   Google Scholar
• Marek S, Bock K, Hellmeyer L, Stein W, Schmidt S. Origin and significance of leptin and neuropeptide Y (NPY) in amniotic fluid between the 14th and 18th weeks of gestation. Z Geburtshilfe Neonatol 2006;210:208–12
   PubMedGoogle Scholar
• Hardie L, Trayhurn P, Abramovich D, Fowler P. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clin Endocrinol (Oxf) 1997;47:101–6
   PubMed Web of Science ®Google Scholar
• Briana DD, Malamitsi-Puchner A. Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci 2009;16:921–37
   PubMed Web of Science ®Google Scholar
• Kautzky-Willer A, Pacini G, Tura A, et al. Increased plasma leptin in gestational diabetes. Diabetologia 2001;44:164–72
   PubMed Web of Science ®Google Scholar
• Qiu C, Williams MA, Vadachkoria S, Frederick IO, Luthy DA. Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Obstet Gynecol 2004;103:519–25
   PubMed Web of Science ®Google Scholar
• Georgiou HM, Lappas M, Georgiou GM, et al. Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol 2008;45:157–65
   PubMed Web of Science ®Google Scholar
• Nanda S, Savvidou M, Syngelaki A, et al. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn 2011;31:135–41
   PubMed Web of Science ®Google Scholar
• Lain KY, Daftary AR, Ness RB, Roberts JM. First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol (Oxf) 2008;69:407–11
   PubMed Web of Science ®Google Scholar
• Williams MA, Qiu C, Muy-Rivera M, et al. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 2004;89:2306–11
   PubMed Web of Science ®Google Scholar
• Baviera G, Corrado F, Dugo C, et al. Midtrimester amniotic fluid adiponectin in normal pregnancy. Clin Chem 2007;53:1723–4
   PubMed Web of Science ®Google Scholar
• Kajantie E, Hytinantti T, Hovi P, Andersson S. Cord plasma adiponectin: a 20-fold rise between 24 weeks gestation and term. J Clin Endocrinol Metab 2004;89:4031–6
   PubMed Web of Science ®Google Scholar
• Chan TF, Su JH, Chung YF, et al. Elevated amniotic fluid leptin levels in pregnant women who are destined to develop preeclampsia. Acta Obstet Gynecol Scand 2006;85:171–4
   PubMed Web of Science ®Google Scholar
• D'Anna R, Baviera G, Cannata ML, et al. Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes. Gynecol Obstet Invest 2007;64:65–8
   PubMed Web of Science ®Google Scholar
• Hill NR, Levy JC, Matthews DR. Expansion of the homeostasis model assessment of beta-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2. Diabetes Care 2013;36:2324–30
   PubMed Web of Science ®Google Scholar
• Tisi DK, Burns DH, Luskey GW, Koski KG. Fetal exposure to altered amniotic fluid glucose, insulin, and insulin-like growth factor-binding protein 1 occurs before screening for gestational diabetes mellitus. Diabetes Care 2011;34:139–44
   PubMed Web of Science ®Google Scholar
• Carpenter MW, Canick JA, Hogan JW, et al. Amniotic fluid insulin at 14–20 weeks' gestation: association with later maternal glucose intolerance and birth macrosomia. Diabetes Care 2001;24:1259–63
   PubMed Web of Science ®Google Scholar
• Carpenter MW, Canick JA, Star J, et al. Fetal hyperinsulinism at 14–20 weeks and subsequent gestational diabetes. Obstet Gynecol 1996;87:89–93
   PubMed Web of Science ®Google Scholar
• Buhling KJ, Monnich J, Henrich W, et al. Association between amniotic fluid insulin in the second trimester, maternal glucose tolerance and fetal malformations. Z Geburtshilfe Neonatol 2004;208:226–31
   PubMedGoogle Scholar
• Zollner U, Ahmadi M, Dietl J. Early diagnosis of gestational diabetes by amniotic fluid insulin levels? Z Geburtshilfe Neonatol 2011;215:98–104
   PubMed Web of Science ®Google Scholar
• Weiss PA, Scholz HS, Haas J, Tamussino KF. Effect of fetal hyperinsulinism on oral glucose tolerance test results in patients with gestational diabetes mellitus. Am J Obstet Gynecol 2001;184:470–5
   PubMed Web of Science ®Google Scholar
• Star J, Canick JA, Palomaki GE, et al. The relationship between second-trimester amniotic fluid insulin and glucose levels and subsequent gestational diabetes. Prenat Diagn 1997;17:149–54
   PubMed Web of Science ®Google Scholar